Nottingham Prognostic Index Plus (NPI+) – A Ground Breaking Tool for Breast Cancer

The Nottingham Prognostic Index Plus (NPI+) is an award winning decision making tool for clinicians to offer personalised medicine to all female patients with breast cancer. NPI+ builds considerably upon the original NPI that was developed in Nottingham in the early 1980s. NPI+ includes ground breaking functionality by predicting both clinical outcomes (survival) and by aiding customised therapeutics. NPI+ can be used for all female breast cancer patients, not just those who are oestrogen receptor positive.